Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients

References

• FanLStrasser-WeipplKLiJJBreast cancer in ChinaLancet Oncol2014157e279e28924872111
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
   PubMed Web of Science ®Google Scholar
• DanalaGPatelBAghaeiFClassification of breast masses using a computer-aided diagnosis scheme of contrast enhanced digital mammogramsAnn Biomed Eng Epub2018510
   Web of Science ®Google Scholar
• JeffersAMSiehWLipsonJABreast cancer risk and mammographic density assessed with semiautomated and fully automated methods and BI-RADSRadiology2017282234835527598536
   PubMed Web of Science ®Google Scholar
• ŁawickiSZajkowskaMGlazewskaEKBędkowskaGESzmitkowskiMPlasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancerOnco Targets Ther2016991191926966379
   PubMed Web of Science ®Google Scholar
• WuJCaoGSunXIntratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapyRadiology20182881263529714680
   PubMed Web of Science ®Google Scholar
• NyanteSJLeeSSBenefieldTSHootsTNHendersonLMThe association between mammographic calcifications and breast cancer prognostic factors in a population-based registry cohortCancer2017123221922727683209
   PubMed Web of Science ®Google Scholar
• XiaoXJiangQWuHGuanXQinWLuoBDiagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in ChinaEur Radiol20172762443245027761708
   PubMed Web of Science ®Google Scholar
• MercadoCLBI-RADS updateRadiol Clin North Am201452348148724792650
   PubMed Web of Science ®Google Scholar
• CenDXuLLiNBI-RADS 3-5 microcalcifications can preoperatively predict breast cancer HER2 and Luminal a molecular subtypeOncotarget201788138551386228099938
   PubMedGoogle Scholar
• BadanGMPiatoSRovedaDJrde Faria Castro FleuryEPredictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS)Eur J Radiol201685101701170727666605
   PubMed Web of Science ®Google Scholar
• KennedyGMarkertMAlexanderJRAvisarEPredictive value of BI-RADS classification for breast imaging in women under age 50Breast Cancer Res Treat2011130381982321748292
   PubMed Web of Science ®Google Scholar
• EvansAWhelehanPThomsonKDifferentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classificationBr J Cancer2012107222422922691969
   PubMed Web of Science ®Google Scholar
• TangSWeiLSunYCA153 in breast secretions as a potential molecular marker for diagnosing breast cancer: a meta analysisPLoS One2016119e016303027636552
   PubMed Web of Science ®Google Scholar
• WuSGHeZYZhouJSerum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancerBreast2014231889324291374
   PubMed Web of Science ®Google Scholar
• YeMHuangTYingYDetection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosisOncotarget2017869230924227999208
   PubMedGoogle Scholar
• CheukIWShinVYKwongADetection of methylated circulating DNA as noninvasive biomarkers for breast cancer diagnosisJ Breast Cancer2017201121928382090
   PubMed Web of Science ®Google Scholar
• ChanMLiawCSJiSMIdentification of circulating microRNA signatures for breast cancer detectionClin Cancer Res201319164477448723797906
   PubMed Web of Science ®Google Scholar
• MishraSSrivastavaAKSumanSKumarVShuklaYCirculating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancerCancer Lett20153691677526276721
   PubMed Web of Science ®Google Scholar
• ZhangLXuYJinXA circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancerBreast Cancer Res Treat2015154242343426476723
   PubMed Web of Science ®Google Scholar
• UehiroNSatoFPuFCirculating cell-free DNA-based epigenetic assay can detect early breast cancerBreast Cancer Res201618112927993161
   PubMed Web of Science ®Google Scholar
• BertucciFFinettiPBirnbaumDMamessierEThe PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancersOncoimmunology201653e108514827141340
   PubMed Web of Science ®Google Scholar
• KatsuyaYHorinouchiHAsaoTExpression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: impact on treatment efficacy and alteration in expression after chemotherapyLung Cancer20169941027565906
   PubMed Web of Science ®Google Scholar
• HuXHuangWFanMEmerging therapies for breast cancerJ Hematol Oncol20171019828454587
   PubMed Web of Science ®Google Scholar
• WakiKYamadaTYoshiyamaKPD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancerCancer Sci2014105101229123525117757
   PubMed Web of Science ®Google Scholar
• SunSFeiXMaoYPD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patientsCancer Immunol Immunother201463439540624514954
   PubMed Web of Science ®Google Scholar
• SorensenSFDemuthCWeberBSorensenBSMeldgaardPIncrease in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinibLung Cancer2016100778427597284
   PubMed Web of Science ®Google Scholar
• MacFarlaneAW4thJillabMPlimackERPD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resectionCancer Immunol Res20142432033124764579
   PubMed Web of Science ®Google Scholar
• LiuCHuangZWangQUsefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancerOnco Targets Ther201694653466027536129
   PubMed Web of Science ®Google Scholar
• VaradanVGilmoreHLMiskimenKLImmune signatures following single dose trastuzumab predict pathologic response to preoperative trastuzumab and chemotherapy in HER2-positive early breast cancerClin Cancer Res201622133249325926842237
   PubMed Web of Science ®Google Scholar
• MulliganAMPinnaduwageDTchatchouSBullSBAndrulisILValidation of intratumoral T-bet+ lymphoid cells as predictors of disease-free survival in breast cancerCancer Immunol Res201641414826546451
   PubMed Web of Science ®Google Scholar
• LiMZhaoFZhangXInvolved-field irradiation in definitive chemoradiotherapy for T4 squamous cell carcinoma of the esophagusCurr Oncol2016232e131e13727122981
   PubMed Web of Science ®Google Scholar
• YuHYangJJiaoSLiYZhangWWangJCytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosisCancer Immunol Immunother201564785386025893809
   PubMed Web of Science ®Google Scholar
• ChenYChenKXiaoXPretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective studyBMC Cancer20161632027198767
   PubMed Web of Science ®Google Scholar
• JangBSKimIAA radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) datasetRadiother Oncol2017124340341028579282
   PubMed Web of Science ®Google Scholar
• HendrickxWSimeoneIAnjumSIdentification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysisOncoimmunology201762e125365428344865
   PubMed Web of Science ®Google Scholar
• LeDTUramJNWangHPD-1 blockade in tumors with mismatch-repair deficiencyN Engl J Med2015372262509252026028255
   PubMed Web of Science ®Google Scholar
• GrosARobbinsPFYaoXPD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumorsJ Clin Invest201412452246225924667641
   PubMed Web of Science ®Google Scholar
• BeckersRKSelingerCIVilainRProgrammed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcomeHistopathology2016691253426588661
   PubMed Web of Science ®Google Scholar
• SchalperKAVelchetiVCarvajalDIn situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomasClin Cancer Res201420102773278224647569
   PubMed Web of Science ®Google Scholar
• TsangJYAuWLLoKYPD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patientsBreast Cancer Res Treat20171621193028058578
   PubMed Web of Science ®Google Scholar
• DuchnowskaRPeksaRRadeckaBImmune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axisBreast Cancer Res20161814327117582
   PubMed Web of Science ®Google Scholar
• DriessensGKlineJGajewskiTFCostimulatory and coinhibitory receptors in anti-tumor immunityImmunol Rev2009229112614419426219
   PubMed Web of Science ®Google Scholar
• DieciMVGriguoloGMigliettaFGuarneriVThe immune system and hormone-receptor positive breast cancer: is it really a dead end?Cancer Treat Rev20164691927055087
   PubMed Web of Science ®Google Scholar
• TataraTMukoharaTShimonoYExpression of programmed death-1 in sentinel lymph nodes of breast cancerJ Surg Oncol201811761131113629193094
   PubMed Web of Science ®Google Scholar
• MuenstSSoysalSDGaoFObermannECOertliDGillandersWEThe presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancerBreast Cancer Res Treat2013139366767623756627
   PubMed Web of Science ®Google Scholar
• LiYGaoPYangJYuHZhuYSiWRelationship between IL-10 expression and prognosis in patients with primary breast cancerTumour Biol20143511115331154025129439
   PubMedGoogle Scholar
• KimJYJungEJParkTPrognostic importance of ultrasound BI-RADS classification in breast cancer patientsJpn J Clin Oncol201545541141525670765
   PubMed Web of Science ®Google Scholar
• JinZQLinMYHaoWQDiagnostic evaluation of ductal carcinoma in situ of the breast: ultrasonographic, mammographic and histopathologic correlationsUltrasound Med Biol2015411475525479813
   PubMed Web of Science ®Google Scholar
• ChangHJYangMJYangYHHouMFHsuehEJLinSRMMP13 is potentially a new tumor marker for breast cancer diagnosisOncol Rep20092251119112719787229
   PubMed Web of Science ®Google Scholar